Changeflow GovPing Pharma & Drug Safety Biofilm Inhibition Compositions for Dental Appl...
Routine Notice Added Final

Biofilm Inhibition Compositions for Dental Applications

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent application EP3435766A1 for Dentsply Sirona Inc., covering compositions and methods for inhibiting and interrupting biofilm formation in dental applications. The application names Xiaoming JIN, Hui LU, Christopher DAMIEN, and Bernard KOLTISKO as inventors and designates all European Patent Convention contracting states including AL, AT, BE, DE, FR, GB, IT, NL, and others.

What changed

EPO published patent application EP3435766A1 for Dentsply Sirona Inc. relating to biofilm inhibition compositions for dental/oral care applications. The patent covers compositions including quaternary ammonium compounds (A01N 33/12), imidazole derivatives (A01N 43/50), and polymeric carriers (A61K 8/81), with applications in oral hygiene products. The filing was published under IPC classifications including A01N, A61K, A61Q, and A01P.

This is a patent application publication notice with no immediate compliance obligations. Companies developing oral care or dental hygiene products containing similar antimicrobial compositions should review the claims to assess potential freedom-to-operate implications. No action is required for entities not operating in the designated European Patent Convention contracting states or not working with similar biofilm inhibition technologies.

Source document (simplified)

← EPO Patent Bulletin

COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION

Publication EP3435766A1 Kind: A1 Mar 25, 2026

Applicants

Dentsply Sirona Inc.

Inventors

JIN, Xiaoming, LU, Hui, DAMIEN, Christopher, KOLTISKO, Bernard

IPC Classifications

A01N 33/12 20060101AFI20171006BHEP A01N 43/50 20060101ALI20171006BHEP A01N 57/34 20060101ALI20171006BHEP A01N 25/10 20060101ALI20171006BHEP A61Q 11/00 20060101ALI20171006BHEP A61K 8/81 20060101ALI20171006BHEP A01P 1/00 20060101ALI20171006BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Compositions and Methods for Inhibition and Interruption of Biofilm Formation

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3435766A1

Who this affects

Applies to
Healthcare providers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Pharmaceuticals Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.